Retraction retracted: efficacy and safety of temozolomide combined with radiotherapy in the treatment of malignant glioma

HIGHLIGHTS

• who: Retraction from the (UNIVERSITY) have published the article: Retraction Retracted: Efficacy and Safety of Temozolomide Combined with Radiotherapy in the Treatment of Malignant Glioma, in the Journal: Journal of Healthcare Engineering of 14/Nov/2022

SUMMARY

Received Published @@

ACRONYMS

LAY DEFINITIONS

• Temozolomide: A dacarbazine derivative that is used as an alkylating antineoplastic agent for the treatment of MALIGNANT GLIOMA and MALIGNANT MELANOMA.
• Glioma: Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.